BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25007999)

  • 1. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.
    Yavuzer S; Yavuzer H; Cengiz M; Erman H; Altıparmak MR; Korkmazer B; Balci H; Simsek G; Yaldıran AL; Karter Y; Uzun H
    J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome.
    Civelek S; Kutnu M; Uzun H; Erdenen F; Altunoglu E; Andican G; Seven A; Sahin AO; Burcak G
    J Clin Lab Anal; 2015 May; 29(3):184-90. PubMed ID: 24798146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
    Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension.
    Huang YQ; Jie LI; Chen JY; Tang ST; Huang C; Feng YQ
    J Hum Hypertens; 2017 Dec; 32(1):40-45. PubMed ID: 29162926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension.
    Yavuzer H; Cengiz M; Yavuzer S; Rıza Altıparmak M; Korkmazer B; Balci H; Yaldıran AL; Uzun H
    J Hum Hypertens; 2016 Jul; 30(7):424-9. PubMed ID: 26040439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of maternal and umbilical cord blood soluble lectin-like oxidized low-density lipoprotein receptor 1 levels in early- and late-onset preeclampsia.
    Tuten A; Erman H; Korkmaz GG; Oncul M; Gelisgen R; Sozer V; Acıkgoz S; Simsek G; Uzun H
    Arch Gynecol Obstet; 2014 Nov; 290(5):1007-13. PubMed ID: 24916561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative stress in white coat hypertension; role of paraoxonase.
    Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
    J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and endothelial dysfunction: A potential role for soluble lectin-like oxidized low density lipoprotein receptor-1.
    Oncul M; Albayrak M; Sozer V; Karakus B; Gelisgen R; Karatas S; Simsek G; Uzun H
    Reprod Biol; 2020 Sep; 20(3):396-401. PubMed ID: 32409108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium and angiogenesis in white coat hypertension.
    Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
    J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease.
    Kobat MA; Fırdolas F; Balin M; Çelik A; Bentli R; Baydas A
    J Sex Med; 2013 Nov; 10(11):2782-9. PubMed ID: 23088332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and nitric oxide level in patients with white coat hypertension.
    Guven A; Tolun F; Caliskan M; Ciftci O; Muderrisoglu H
    Blood Press; 2012 Oct; 21(5):281-5. PubMed ID: 22229480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Carbamylated LDL, Nitrotyrosine and Soluble Lectin-like Oxidized Low-density Lipoprotein Receptor-1 in Poorly Controlled Type 2 Diabetes Mellitus.
    Stankova TR; Delcheva GT; Maneva AI; Vladeva SV
    Folia Med (Plovdiv); 2019 Sep; 61(3):419-425. PubMed ID: 32337929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study.
    Yokota C; Sawamura T; Watanabe M; Kokubo Y; Fujita Y; Kakino A; Nakai M; Toyoda K; Miyamoto Y; Minematsu K
    J Atheroscler Thromb; 2016 Oct; 23(10):1222-1226. PubMed ID: 27025681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.
    Markstad H; Edsfeldt A; Yao Mattison I; Bengtsson E; Singh P; Cavalera M; Asciutto G; Björkbacka H; Fredrikson GN; Dias N; Volkov P; Orho-Melander M; Nilsson J; Engström G; Gonçalves I
    J Am Heart Assoc; 2019 Feb; 8(4):e009874. PubMed ID: 30744454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia.
    English FA; McCarthy FP; McSweeney CL; Quon AL; Morton JS; Sawamura T; Davidge ST; Kenny LC
    Am J Hypertens; 2013 Feb; 26(2):279-86. PubMed ID: 23382414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus.
    Shiu SW; Tan KC; Wong Y; Leng L; Bucala R
    Atherosclerosis; 2009 Apr; 203(2):522-7. PubMed ID: 18755461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension.
    Cengiz M; Yavuzer S; Kılıçkıran Avcı B; Yürüyen M; Yavuzer H; Dikici SA; Karataş ÖF; Özen M; Uzun H; Öngen Z
    Clin Exp Hypertens; 2015; 37(8):643-9. PubMed ID: 26114349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOX-1 in atherosclerotic disease.
    Sawamura T; Wakabayashi I; Okamura T
    Clin Chim Acta; 2015 Feb; 440():157-63. PubMed ID: 25463747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.